Related Experiment Video

Updated: Jul 13, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

Should beta blockers be used in the treatment of hypertension in the elderly?

L Michael Prisant1

  • 1Hypertension Unit, Section of Cardiology, Medical College of Georgia, Augusta 30912-3105, USA. mprisant@mail.mcg.edu

Journal of Clinical Hypertension (Greenwich, Conn.)
|July 31, 2002
PubMed

Insights

Beta blockers offer significant benefits for elderly patients with hypertension, reducing strokes and heart failure. Despite concerns, these drugs are vital for managing cardiovascular risks in older adults.

Area of Science:

  • Cardiology
  • Geriatrics
  • Pharmacology

Background:

  • Concerns exist regarding beta blocker safety and efficacy in the elderly hypertensive population.
  • Some recommendations suggest avoiding beta blockers for hypertension management in older adults.

Purpose of the Study:

  • To evaluate the benefits of beta blockers in elderly hypertensive patients.
  • To address the overstated risks and underappreciated benefits of beta blockers in this demographic.

Main Methods:

  • Review of existing literature and national statistics on beta blocker use in the elderly.
  • Analysis of outcomes such as stroke, congestive heart failure, and myocardial infarction.

Main Results:

  • Beta blockers have demonstrated a reduction in strokes and congestive heart failure in elderly hypertensive individuals.
  • Evidence supports beta blockers in reducing mortality post-myocardial infarction, including sudden cardiac death.
  • Beta blockers are effective adjuncts to ACE inhibitors in managing congestive heart failure mortality.

Conclusions:

  • Beta blockers provide significant cardiovascular benefits for elderly hypertensive patients, particularly those with ischemic heart disease, arrhythmias, or heart failure.
  • The perceived risks of beta blockers in the elderly are often overstated, and their benefits are substantial.
  • Continued use of beta blockers is recommended for managing hypertension and associated cardiovascular conditions in older adults.

Related Concept Videos

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers01:27

Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers

β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in bronchial smooth...
Adrenergic Antagonists: ɑ and β-Receptor Blockers01:31

Adrenergic Antagonists: ɑ and β-Receptor Blockers

Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is clinically...
Antihypertensive Drugs: Action of β1 Blockers01:17

Antihypertensive Drugs: Action of β1 Blockers

β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this, β1-blockers...
Antihypertensive Drugs: Types of β-Blockers01:28

Antihypertensive Drugs: Types of β-Blockers

β receptors are classified into three subclasses: β1, β2, and β3. β1 receptors are primarily located in the heart and kidneys. When they get activated, they increase heart rate, contractility, and renin release. This process enhances blood pressure and aids in stress management. In contrast, β2 receptors are situated mainly in the lungs, blood vessels, and skeletal muscles. Upon activation, they trigger smooth muscle relaxation, causing bronchodilation and vasodilation. This widens airways and...
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...